XFOR

USD

X4 Pharmaceuticals Inc. Common Stock

$3.970-0.030 (-0.750%)

السعر في الوقت الحقيقي

Healthcare

التكنولوجيا الحيوية

الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق

أساسيات الشركة

إحصاءات التداول

مقاييس السوق

الافتتاح

$4.000

الأعلى

$4.120

الأدنى

$3.940

الحجم

0.20M

أساسيات الشركة

القيمة السوقية

314.5M

الصناعة

التكنولوجيا الحيوية

البلد

United States

إحصاءات التداول

متوسط الحجم

4.09M

البورصة

NCM

العملة

USD

نطاق 52 أسبوعاً

الأدنى $1.35الحالي $3.970الأعلى $26.82

أخبار ذات صلة

١٠ نوفمبر ٢٠٢٥ · ١٢:٠٩ م

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals with a Buy and raises the price target from $3.5 to $5.

عرض المزيد

HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5

٢٧ أكتوبر ٢٠٢٥ · ١١:٠٥ م

GlobeNewswire

X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million

BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with rare hematology diseases, today announced the closing of its

عرض المزيد

X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million

٢٤ أكتوبر ٢٠٢٥ · ٠٤:٣٧ ص

GlobeNewswire

X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering

BOSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with rare hematology diseases, today announced the pricing of its

عرض المزيد